Peter Ordentlich is CSO at Syndax Pharmaceuticals Inc (SNDX). They have made 8 open-market trades across 1 company since 2017, most recently 2023-02-15.
CIK 0001594274
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 8 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| SNDX | 17,428 | $225K |
Shares reported on the most recent Form 4, priced at the 2023-02-17 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SNDX | SELL | 2023-02-15 | 2023-02-17 | $25.84 | $1.3M | -6.7% | -10.5% | -17.8% |
| SNDX | SELL | 2023-02-01 | 2023-02-03 | $28.43 | $2K | -6.4% | -12.3% | -27.7% |
| SNDX | SELL | 2022-12-01 | 2022-12-02 | $25.03 | $821K | -1.7% | +2.4% | -3.5% |
| SNDX | SELL | 2022-08-24 | 2022-08-26 | $25.04 | $1.3M | +9.7% | +1.1% | -3.1% |
| SNDX | SELL | 2022-02-01 | 2022-02-03 | $16.65 | $24K | +10.4% | +9.7% | +16.7% |
| SNDX | SELL | 2020-11-23 | 2020-11-25 | $23.16 | $1.4M | +4.5% | +5.0% | -2.9% |
| SNDX | SELL | 2018-04-03 | 2018-04-03 | $15.00 | $113K | -20.4% | -27.0% | -50.9% |
| SNDX | SELL | 2017-05-17 | 2017-05-19 | $15.00 | $75K | -12.0% | -17.1% | -23.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.